ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
- Total 13F shares
- 91,217,786
- Share change
- -960,074
- Total reported value
- $1,963,307,213
- Put/Call ratio
- 97%
- Price per share
- $21.53
- Number of holders
- 176
- Value change
- -$33,485,873
- Number of buys
- 92
- Number of sells
- 75
Quarterly Holders Quick Answers
What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 77313F106:
Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
—
mixed-class rows
|
18,037,772
mixed-class rows
|
$476,613,298 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8.4%
|
9,156,099
|
$246,665,307 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
5,929,910
|
$159,751,774 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
5,370,885
|
$144,691,641 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
4,193,077
|
$112,961,494 | — | 31 Mar 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
3.6%
|
3,984,030
|
$107,329,768 | — | 31 Mar 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.6%
|
3,888,312
|
$104,751,125 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.7%
|
2,943,160
|
$79,290,000 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.4%
|
2,606,016
|
$70,170,100 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
mixed-class rows
|
2,834,636
mixed-class rows
|
$66,645,917 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.7%
|
1,867,329
|
$50,305,843 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.6%
|
1,801,068
|
$48,520,772 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.4%
|
1,561,230
|
$42,059,536 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,502,587
|
$40,486,504 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
1,466,051
|
$39,495,414 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
1,323,447
|
$35,653,662 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
1.2%
|
1,300,000
|
$35,022,000 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.2%
|
1,260,900
|
$33,968,646 | — | 31 Mar 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
—
mixed-class rows
|
1,129,063
mixed-class rows
|
$29,642,695 | — | 31 Mar 2024 | |
| Novo Holdings A/S |
13F
|
Company |
0.96%
|
1,050,000
|
$28,287,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.94%
|
1,029,788
|
$27,742,489 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.94%
|
1,025,000
|
$27,613,500 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.93%
|
1,018,488
|
$27,438,067 | — | 31 Mar 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.91%
|
990,544
|
$26,685,255 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.63%
|
688,813
|
$18,556,623 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.62%
|
682,524
|
$18,387,198 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.62%
|
675,769
|
$18,205,228 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
660,000
|
$17,780,400 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
610,037
|
$16,434,396 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.53%
|
576,667
|
$15,535,406 | — | 31 Mar 2024 | |
| COMERICA BANK |
13F
|
Company |
0.49%
|
534,525
|
$14,400,104 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
532,563
|
$14,347,247 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
509,053
mixed-class rows
|
$13,711,251 | — | 31 Mar 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
490,732
|
$13,220,320 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
430,875
|
$11,607,761 | — | 31 Mar 2024 | |
| M28 Capital Management LP |
13F
|
Company |
0.35%
|
385,680
|
$10,390,219 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.3%
|
329,043
|
$8,864,418 | — | 31 Mar 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.3%
|
326,787
|
$8,803,642 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.27%
|
300,000
|
$8,082,000 | — | 31 Mar 2024 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
297,658
|
$8,018,907 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.27%
|
297,096
|
$8,003,767 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.26%
|
285,143
|
$7,681,752 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.25%
|
275,720
|
$7,427,897 | — | 31 Mar 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.23%
|
250,870
|
$6,758,438 | — | 31 Mar 2024 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.22%
|
235,050
|
$6,332,247 | — | 31 Mar 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.21%
|
231,287
|
$6,230,872 | — | 31 Mar 2024 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.21%
|
230,000
|
$6,196,200 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
217,356
|
$5,855,576 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.17%
|
183,722
|
$4,949,471 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.28%
|
301,832
|
$4,906,719 | — | 31 Mar 2024 |
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q2 2024
As of 30 Jun 2024,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,217,786 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, MAVERICK CAPITAL LTD, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, and STATE STREET CORP.
This page lists
176
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
183
Q2 2024 holders
176
Holder diff
-7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.